Patent US7270675B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US7270675B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Method of forming a tubular membrane on a structural frame

Assignee: Cordis US Corp
•
Filing: 2003-03-28
•
Granted: 2007-09-18
•
Expires: 2023-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a medical device and method of forming the medical device. In particular, the present invention relates to a medical device having a tubular membrane structure over a radially expandable structural frame, and to a method of forming the tubular membrane on the radially expandable structural frame. In one aspect, a structural frame is placed over a spinning mandrel and a fiber is electro-statically spun over at least a portion of the structural frame forming a membrane. A transfer sheath may be used between the mandrel and structural frame to prevent the electro-statically spun fiber from adhering to the mandrel. In another aspect, a first membrane is spun over the mandrel before the structural frame is placed over the mandrel. In this aspect, at least a portion of the structural frame is sandwiched between the membranes. The membrane or membranes and structural frame form a fiber spun frame assembly. The fiber spun frame assembly may be coated with an elastic polymer. In addition, the membrane or membranes may go through some post processing to achieve desired characteristics or configurations.

Inventors

  • 👤 Iksoo Chun
  • 👤 Mark B. Roller
  • 👤 David Christopher Majercak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 20:57
CPC Classifications
D; D04; D04H; D04H3/00; D04H3/02; D04H3/07; A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61F2/2415; A61F2/2418; A61F2/2475; A61F2/82; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61L; A61L27/00; A61L27/14; A61L27/18; A61L27/28; A61L27/34; A61L27/50; A61L27/54; D01; D01D; D01D5/00; D01D5/0007; D01D5/0061; D01D5/0076; D01D5/0084; D01F; D01F6/00; D01F6/28; D01F6/32; D01F6/78; D01F6/84; A61F2002/825; A61F2002/91533; A61F2002/9155; A61F2002/91558; A61F2002/91575; A61F2002/91583; A61F2220/00; A61F2220/0025; A61F2220/0058; A61F2230/00; A61F2230/0002; A61F2230/0028; A61F2230/0054; A61L2300/00

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 161 words
A medical device having a tubular membrane structure comprising: a radially expandable structural frame, including a proximal anchor having a substantially cylindrical configurations with first and second open ends and a longitudinal axis extending there between, and a plurality of connecting members each having a first and a second end and being oriented parallel to the longitudinal axis, wherein the first end of each connecting member is attached to the proximal anchor; a polymer fiber membrane electrostatically spun over at least a portion of the exterior surface of the connecting members; and a polymeric outer membrane coated over the fiber membrane, the polymeric outer membrane and fiber membrane combining to form the tubular membrane structure, the tubular membrane structure terminating with a plurality of, supple valve flaps, each supple valve flap having a distally oriented leading edge defined along the circumference of the tubular membrane structure by adjacent connecting members, wherein the leading edge of the supple valve flap is frameless.
Claim 2
Dependent Claim 161 words
A medical device having a tubular membrane structure comprising: a radially expandable structural frame, including a proximal anchor having a substantially cylindrical configurations with first and second open ends and a longitudinal axis extending there between, and a plurality of connecting members each having a first and a second end and being oriented parallel to the longitudinal axis, wherein the first end of each connecting member is attached to the proximal anchor; a polymer fiber membrane electrostatically spun over at least a portion of the exterior surface of the connecting members; and a polymeric outer membrane coated over the fiber membrane, the polymeric outer membrane and fiber membrane combining to form the tubular membrane structure, the tubular membrane structure terminating with a plurality of, supple valve flaps, each supple valve flap having a distally oriented leading edge defined along the circumference of the tubular membrane structure by adjacent connecting members, wherein the leading edge of the supple valve flap is frameless.
Claim 3
Dependent Claim 14 words
The medical device of claim 1 wherein the polymer fiber membrane comprises a fluoropolymer.
Claim 4
Dependent Claim 28 words
The medical deice of claim 2 wherein the fluoropolymer is a vinylidene fluoride/hexofluoropropylene having a weight to weight ratio in the range from about 75%/25% to about 100%/0%.
Claim 5
Dependent Claim 15 words
The medical device of claim 1 wherein the polymer fiber membrane is a bioabsorbable polymer.
Claim 6
Dependent Claim 25 words
The medical device of claim 4 wherein the bioabsorbable polymer is a polylactic acid/polycaprolactone having a weight to weight ratio of between 50%/50% and 70%/30%.
Claim 7
Dependent Claim 25 words
The medical device of claim 4 wherein the bioabsorbable polymer is a polyglycolic acid/polycaprolactone having a weight to weight ratio of between 50%/50% and 70%/30%.
Claim 8
Dependent Claim 23 words
The medical device of claim 1 wherein the polymer fiber membrane comprises a bioabsorbable polymer from the group consisting of homopolymers and copolymers.
Claim 9
Dependent Claim 29 words
The medical device of claim 1 wherein the polymer fiber membrane comprises a polymer from the group consisting of nonabsorbable siliconized polyurethane, non-siliconized polyurethane, siliconized polyureaurethane and natural polymers.
Claim 10
Dependent Claim 15 words
The medical device of claim 1 wherein the polymer fiber membrane comprises a therapeutic agent.
Claim 11
Dependent Claim 15 words
The medical device of claim 1 wherein the polymer fiber membrane comprises a pharmaceutic agent.
Claim 12
Dependent Claim 26 words
The medical device of claim 1 wherein the polymer fiber membrane has a wall thickness in the range from about 5 μm to about 100 μm.
Claim 13
Dependent Claim 13 words
The medical device of claim 1 wherein the outer membrane comprises a polymer.
Claim 14
Dependent Claim 12 words
The medical device of claim 12 wherein the polymer is a fluoropolymer.
Claim 15
Dependent Claim 28 words
The medical deice of claim 13 wherein the fluoropolymer is a vinylidene fluoride/hexofluoropropylene having a weight to weight ratio in the range from about 50%/50% to about 70%/30%.
Claim 16
Dependent Claim 12 words
The medical device of claim 12 wherein the polymer is siliconized polyurethane.
Claim 17
Dependent Claim 12 words
The medical device of claim 12 wherein the polymer is non-siliconized polyurethane.
Claim 18
Dependent Claim 13 words
The medical device of claim 12 wherein the polymer comprises a therapeutic agent.
Claim 19
Dependent Claim 13 words
The medical device of claim 12 wherein the polymer comprises a pharmaceutic agent.
Claim 20
Dependent Claim 26 words
The medical device of claim 1 wherein the tubular membrane structure has a wall thickness in the range from about 5 μm to about 100 μm.

References Cited (Backward Citations)

US4323525A Cited
US4475972A Cited
US4892541A Cited
US4692164A Cited
US4790843A Cited
US4725274A Cited
US5156621A Cited
US5032128A Cited
US4969896A Cited
US5824061A Cited
US5609626A Cited
US5500014A Cited
US5997573A Cited
US5147391A Cited
US5037434A Cited
US6168614B1 Cited
US5840081A Cited
US5411552A Cited
US5415667A Cited
US5489298A Cited
US5423887A Cited
US5163955A Cited
US5326370A Cited
US5326371A Cited
US5449385A Cited
US5344442A Cited
US5358518A Cited
US5876445A Cited
US5123919A Cited
US5163953A Cited
US5469868A Cited
US5258023A Cited
US5449384A Cited
US5607463A Cited
US6375787B1 Cited
US5549665A Cited
US6309413B1 Cited
US5480424A Cited
US5607465A Cited
US5612885A Cited
US5938696A Cited
US5843181A Cited
US5697382A Cited
US5554185A Cited
US5562729A Cited
US6124523A Cited
US6355056B1 Cited
US5728152A Cited
US5895420A Cited
US6165216A Cited
US6068638A Cited
US6071277A Cited
EP0808614A2 Cited
US5855601A Cited
US5855602A Cited
US5861028A Cited
US6086610A Cited
US6315791B1 Cited
US6287334B1 Cited
EP0850607A1 Cited
US5851232A Cited
US5928281A Cited
US5957949A Cited
US6245102B1 Cited
US5855597A Cited
US5910170A Cited
EP0928606A1 Cited
EP0938879A2 Cited
US5935163A Cited
US6200336B1 Cited
FR2788217A1 Cited
WO2000047139A1 Cited
WO2000047136A1 Cited
US6283995B1 Cited
US6228112B1 Cited
US6296662B1 Cited
US6299637B1 Cited
US20020124953A1 Cited
WO2001028459A1 Cited
US20020188348A1 Cited
WO2001049213A2 Cited
US6245100B1 Cited
WO2001067992A1 Cited
US20020032481A1 Cited
WO2002026139A1 Cited
US20020133183A1 Cited
EP1192957A2 Cited
US6494909B2 Cited
US20020138135A1 Cited
US20040030377A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2010-09-17 2011-03-19 2011-09-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2014-09-17 2015-03-19 2015-09-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2018-09-17 2019-03-19 2019-09-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag